CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus

By Moldoveanu Z.   Love-Homan L.   Huang W.Q.   Krieg A.M.  

Vaccine, Vol. 16, Iss. 11, 1998-07 ,pp. : 1216-1224

Elsevier

Access to resources Recommend Favorite

Immunostimulatory DNA as adjuvant: efficacy of phosphodiester CpG oligonucleotides is enhanced by 3' sequence modifications

By Zimmermann S.   Heeg K.   Dalpke A.  

Vaccine, Vol. 21, Iss. 9, 2003-02 ,pp. : 990-995

Elsevier

Access to resources Recommend Favorite

Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine

By Kojima Y.   Xin K.-Q.   Ooki T.   Hamajima K.   Oikawa T.   Shinoda K.   Ozaki T.   Hoshino Y.   Jounai N.   Nakazawa M.   Klinman D.   Okuda K.  

Vaccine, Vol. 20, Iss. 23, 2002-07 ,pp. : 2857-2865

Elsevier

Access to resources Recommend Favorite

CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans

By Davis H.L.   Suparto I.I.   Weeratna R.R.   Jumintarto   Iskandriati D.D.   Chamzah S.S.   Ma'ruf A.A.   Nente C.C.   Pawitri D.D.   Krieg A.M.   Heriyanto   Smits W.   Sajuthi D.D.  

Vaccine, Vol. 18, Iss. 18, 2000-03 ,pp. : 1920-1924

Elsevier

Access to resources Recommend Favorite

CpG DNA induces stronger immune responses with less toxicity than other adjuvants

By Weeratna R.D.   McCluskie M.J.   Xu Y.   Davis H.L.  

Vaccine, Vol. 18, Iss. 17, 2000-03 ,pp. : 1755-1762

Elsevier

Access to resources Recommend Favorite